CDK4 and neoplasm: Within our unselected cohort of high-grade osteosarcomas, 5% exhibited amplification of CDK4 alone, and only 3% displayed amplification of both CDK4 and MDM2. It is noteworthy that these amplification patterns are somewhat mirrored in other tumour types.